Cryoport (CYRX) Common Equity (2011 - 2026)

Cryoport (CYRX) has 16 years of Common Equity data on file, last reported at $495.0 million in Q1 2026.

• Common Equity for Q1 2026 came in at $495.0 million, up 24.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $495.0 million (up 24.12% YoY), and the FY2025 annual result was $502.6 million, up 25.07% from the prior year.
• Common Equity fell to $495.0 million in Q1 2026 per CYRX's latest filing, from $502.6 million in the prior quarter.
• Over five years, Common Equity peaked at $609.4 million in Q1 2022 and troughed at $398.8 million in Q1 2025.
• A 5-year average of $502.5 million and a median of $513.3 million in 2025 frame the typical range for Common Equity.
• The sharpest annual moves came in 2024 and 2025: Common Equity slipped 26.49% in 2024, then gained 29.74% in 2025.
• A 5-year view of Common Equity shows it stood at $555.8 million in 2022, then slipped by 12.02% to $489.0 million in 2023, then fell by 17.82% to $401.9 million in 2024, then increased by 25.07% to $502.6 million in 2025, then dropped by 1.52% to $495.0 million in 2026.
• Business Quant data shows CYRX's Common Equity at $495.0 million in Q1 2026, $502.6 million in Q4 2025, and $513.3 million in Q3 2025.